Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors

C J Larkin, [No Value] Watson RGP, J M Sloan, M Stevenson, J E Ardill, D Buchanan, Peter Watson

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Gastric atrophy is associated with Helicobacter pylori infection. Conflicting results have been obtained as to whether acid suppressant therapy hastens the development or changes the distribution of atrophy in the stomach. The aim of this study was to investigate whether concomitant proton pump inhibitor (PPI) therapy in H. pylori-infected individuals resulted in an increase or an alteration in atrophy distribution and whether this was reflected by the plasma gastrin.
Original languageEnglish
Pages (from-to)578-82
Number of pages5
JournalScandinavian Journal of Gastroenterology
Volume35
Issue number6
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors'. Together they form a unique fingerprint.

  • Cite this

    Larkin, C. J., Watson RGP, N. V., Sloan, J. M., Stevenson, M., Ardill, J. E., Buchanan, D., & Watson, P. (2000). Distribution of atrophy in Helicobacter pylori-infected subjects taking proton pump inhibitors. Scandinavian Journal of Gastroenterology, 35(6), 578-82.